Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trialJony van Hilst, Ferry A.L.M. Eskens, Sebastiaan Festen et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 597
Molecular subtyping of cancer: current status and moving toward clinical applicationsLan Zhao, Maarten F. Bijlsma, Victor Lee et al.|Briefings in Bioinformatics|2018Cited by 150
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1Anne Steins, Maarten F. Bijlsma|EMBO Reports|2020Cited by 39
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenuesAndrea Vallés‐Martí, Maarten F. Bijlsma|Molecular Oncology|2024Cited by 9
Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinomaDajia Liu, Maarten F. Bijlsma|Pharmacological Research|2024Cited by 4